Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (KCT0012349) titled 'An 8-week, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lactobacillus paracasei HY7017 in enhancing immune function' on July 28.

Study Type: Interventional Study

Study Design: Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Vievis Namuh Hospital

Condition:

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Intervention: Dietary Supplement : Participants who voluntarily sign the informed consen...